Search Results

There are 10695 results for: content related to: Therapy of hepatitis C: Alpha interferon and ribavirin

  1. You have free access to this content
    Synthesis and Evaluation of Bile Acid–Ribavirin Conjugates as Prodrugs to Target the Liver

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 9, September 2015, Pages: 2864–2876, Zhongqi Dong, Qing Li, Dong Guo, Yan Shu and James E. Polli

    Version of Record online : 2 FEB 2015, DOI: 10.1002/jps.24375

  2. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  3. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  4. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  5. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 2 DEC 2008, DOI: 10.1002/hep.22759

  6. You have free access to this content
    Hepatitis C virus: How genetic variability affects pathobiology of disease

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue s1, January 2011, Pages: 83–95, Kazuaki Chayama and C Nelson Hayes

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1440-1746.2010.06550.x

  7. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  8. Pharmacokinetics and Safety of Viramidine, a Prodrug of Ribavirin, in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 44, Issue 3, March 2004, Pages: 265–275, Chin-Chung Lin, Lee Philips, Christine Xu and Li-Tain Yeh

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004262974

  9. Mechanisms of action of ribavirin against distinct viruses

    Reviews in Medical Virology

    Volume 16, Issue 1, January/February 2006, Pages: 37–48, Jason D. Graci and Craig E. Cameron

    Version of Record online : 15 NOV 2005, DOI: 10.1002/rmv.483

  10. You have free access to this content
    AASLD Abstract (pp. 162A–266A)

    Hepatology

    Volume 40, Issue S4, October 2004, Pages: 267A–369A,

    Version of Record online : 10 FEB 2006, DOI: 10.1002/hep.1840400504

  11. You have free access to this content
    AASLD Abstracts (pp. 687A–784A)

    Hepatology

    Volume 38, Issue S4, October 2003, Pages: 687A–784A,

    Version of Record online : 10 FEB 2006, DOI: 10.1002/hep.1840380509

  12. Ascending Multiple-Dose Pharmacokinetics of Viramidine, a Prodrug of Ribavirin, in Adult Subjects With Compensated Hepatitis C Infection

    The Journal of Clinical Pharmacology

    Volume 45, Issue 3, March 2005, Pages: 275–285, Dr Sanjee Aora, Dr Christine Xu, Ms Alice Teng, Ms Janet Peterson, Dr Li-Tain Yeh, Dr Robert Gish, Dr Daryl Lau, Dr Stephen Rossi and Dr Chin-chung Lin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004270152

  13. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22645

  14. Current Therapies for Chronic Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 1, January 2011, Pages: 92–111, McKenzie C. Ferguson

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.1.92

  15. You have free access to this content
    Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon α-2b and ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1346–1353, A. MANGIA, O. DALGARD, N. MINERVA, H. VERBAAN, D. BACCA, H. RING-LARSEN, M. COPETTI, V. CARRETTA, V. PIAZZOLLA, R. COZZOLONGO, L. MOTTOLA and A. ANDRIULLI

    Version of Record online : 8 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04290.x

  16. Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: 245–251, C. Pedersen, Å. Alsiö, M. Lagging, N. Langeland, M. Färkkilä, M. Rauning Buhl, K. Mørch, J. Westin, P. Sangfelt, G. Norkrans, P. Brehm Christensen and for the NORDynamicIC Study Group

    Version of Record online : 1 APR 2010, DOI: 10.1111/j.1365-2893.2010.01303.x

  17. Epoetin alfa for the Treatment of Combination Therapy–Induced Hemolytic Anemia in Patients Infected with Hepatitis C Virus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 6, June 2005, Pages: 862–875, Dr. Anastasia M. Rivkin and Sweta Chawla

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.6.862

  18. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22017

  19. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  20. You have free access to this content
    Ribavirin inhibits protein synthesis and cell proliferation induced by mitogenic factors in primary human and rat hepatocytes

    Hepatology

    Volume 27, Issue 6, June 1998, Pages: 1687–1694, Gennady P. Ilyin, Sophie Langouët, Maryvonne Rissel, Jean-Guy Delcros, Andre Guillouzo and Christiane Guguen-Guillouzo

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510270630